ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

Published:2019-04 Issue:4 Volume:25 Page:625-638
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Lee Daniel W.,Santomasso Bianca D.,Locke Frederick L.^ORCID,Ghobadi Armin^ORCID,Turtle Cameron J.,Brudno Jennifer N.,Maus Marcela V.^ORCID,Park Jae H.,Mead Elena,Pavletic Steven,Go William Y.,Eldjerou Lamis,Gardner Rebecca A.,Frey Noelle,Curran Kevin J.,Peggs Karl,Pasquini Marcelo^ORCID,DiPersio John F.,van den Brink Marcel R.M.,Komanduri Krishna V.,Grupp Stephan A.,Neelapu Sattva S.

Funder

American Society for Transplantation and Cellular Therapy

American Society of Hematology

National Cancer Institute

Celgene

Novartis

Genentech

,

Amgen

and

GlaxoSmithKline

Roche

Merck

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference41 articles.

1. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

2. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

3. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial;Locke;Lancet Oncol,2019

4. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

5. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy;Fry;Nat Med,2018

Cited by 1996 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nursing Considerations for the Clinical Management of Adverse Events Associated with Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma;Seminars in Oncology Nursing;2024-10

2. CAR T-cell therapy in cancer: Integrating nursing perspectives for enhanced patient care;Asia-Pacific Journal of Oncology Nursing;2024-10

3. Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy;Blood Advances;2024-09-24

4. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies;Blood;2024-09-12

5. Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy;Frontiers in Immunology;2024-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3